Time in range is a powerful metric for modern diabetes management but a new survey finds less than half of people with insulin-treated diabetes are even using it.1 Visit Dexcom.com/InRange to learn
Comprehensive Wearable Medical Devices Help Improve Patient Care
- FinancialBuzz.com News Commentary
NEW YORK, May 6, 2021 /PRNewswire/ A new trend has been evolving in the medical technology sector: wearable medical devices. In the modern technologically-driven healthcare landscape, the business model of medical device companies has evolved from device makers to problem solvers. And, among the many examples, medical device manufacturers are now leveraging the Internet of Things (IoT) and the cloud to improve clinical workflow, help physicians remotely monitor patients with real-time data and analytics solutions and utilize innovative processes to cut costs and improve outcomes. The evolving variables of IoT in the healthcare sector are also one of the major growth indicators that hold a great potential in improving the lifestyle of patients. Overall, the global wearable medical device market size is expected to reach USD 29.6 Billion by 2026 and register a Compound Annual Growth
Advanced Sensor Technology Enables a Modernized Approach to Healthcare
News provided by
Share this article
FinancialBuzz.com News Commentary
NEW YORK, May 5, 2021 /PRNewswire/ Wearable medical devices are now playing a larger role in the healthcare industry than ever before. The growing usage of such devices is, in large part, attributed to the continuous modernization of the healthcare infrastructure, growing prevalence of chronic medical diseases, and the escalating geriatric population which are all augmenting the market growth. Additionally, the outbreak of the pandemic has seen the demand for wearable medical devices accelerate as it has become of paramount importance to monitor patient health remotely and to be able to address concerns in a timely manner. Generally, such devices are designed to monitor physiological parameters, for instance, blood sugar levels and blood pressure, as well as heart rate variability, breathing rate, and skin temperature. And, according to
DexCom, Inc.: Dexcom Starts Direct Distribution in the Netherlands
Dexcom G6 CGM means no more fingersticks for people with diabetes or Dexcom receiver
Share glucose levels with up to five followers for additional remote monitoring
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today it has ended its distribution collaboration with Zkope Healthcare and is now selling the Dexcom G6 CGM system directly throughout the Netherlands. At Dexcom, we are committed to expanding access to CGM for people with diabetes around the world. Being direct in market represents a significant step forward in allowing us to provide the best standard of care in diabetes management, bringing CGM technology to patients and healthcare providers across the Netherlands, said Erik Bjorkman, general manager and senior vice president for EMEA at Dexcom.